Rekvina Laboratories Ltd.
Snapshot View

3.78 0.00

26 July 2021, 04:00:00 P.M.
Volume: 73

Overview View Details

Sector Trading Compare with Sector peers
Industry Trading Compare with Industry peers
Website
Financial Indicators
Market Cap 2.28 Cr.
Earnings per share (EPS) -0.11 Trailing Twelve Months Ending 2021-03
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2021-03
Industry PE 117.90 Trailing Twelve Months Ending 2021-03
Book Value / Share 0.15 Trailing Twelve Months Ending 2021-03
Price to Book Value 24.85 Calculated using Price: 3.78
Dividend Yield 0.00 Period Ending 2018-03
No. of Shares Subscribed 0.60 Cr. 6,028,000 Shares
FaceValue 5
Company Profile

From a small domestic company at inception in middle of 80’s, Rekvina Laboratories has grown formidably to be an integrated, Indian pharmaceutical company. The company has introduced the concept of Dispersible Kid Tablets for Pediatric patients. The company’s unique formulations include its prestigious product ‘REKFA’, (Essential Fatty Acid - in Capsule, Cream & Pediatric Drop). Enthused by the market response, the group introduced many more specialised quality products for Human Health Care. The company has introduced highly specialized products for Gynecological specialty and finally introduced its prestigious product ‘REKSEAL’ (Enbucrilate – n-Butylcyanoacrylate), the Tissue Adhesive which has further added a feather of success in its cap and lead to the introduction of still more specialised products.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
1 Week
1 Month
+5.00%
3 Month
-4.79%
6 Month
-9.35%
1 Year
-9.35%
2 Year
-25.15%
5 Year
-29.35%
8 years 2011-03 2012-03 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03
Return on Equity (%) -1.28 2.50 2.60 3.34 0.64 -10.61 -3.89 -17.92
Return on Capital Employed (%) -1.28 4.95 3.22 4.16 0.81 -10.39 -3.28 -12.59
Return on Assets (%) -1.27 2.46 2.44 2.99 0.56 -8.69 -2.69 -10.03

Balance Sheet View Details

Particulars 8 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr.
Shh. Funds 1 1 1 1 1 1 0 0
Non Curr. Liab.
Curr. Liab. 0 0 0 0 0 0 0
Minority Int.
Equity & Liab. 1 1 1 1 1 1 1 1
Non Curr. Assets 0 0 0 0 0 0 0 0
Curr. Assets 0 0 0 0 0 0 1 1
Misc. Exp. not W/O
Total Assets 1 1 1 1 1 1 1 1

Profit Loss View Details

Particulars 8 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr.
Net Sales 0 0 0 0 0
Other Income 0 0
Total Income 0 0 0 0 0 0 0
Total Expenditure 0 0 0 0 0 0 0 0
PBIDT 0 0 0 0 0 0 0 0
Interest 0
Depreciation
Taxation 0
Exceptional Items
PAT 0 0 0 0 0 0 0

Cash Flow View Details

Particulars 8 years 2011-03 Rs. Cr. 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0
Cash Fr. Inv. 0 0 0 0
Cash Fr. Finan. 0 0 0
Net Change 0 0 0
Cash & Cash Eqvt 0 0 0

Shareholding Pattern View Details

9 Qtrs 2019-03 (%) 2019-06 (%) 2019-09 (%) 2019-12 (%) 2020-03 (%) 2020-06 (%) 2020-09 (%) 2021-03 (%) 2021-06 (%)
Promoter 41.30 41.30 41.30 41.30 41.30 41.30 41.30 41.30 41.30
Public 58.70 58.70 58.70 58.70 58.70 58.70 58.70 58.70 58.70
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Tue, 20 Jul 2021
Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter
0110
Name of the Signatory :- Amit Shah
Designation :- Any Other
Tue, 20 Jul 2021
Shareholding for the Period Ended June 30 2021
Rekvina Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30 2021. For more details kindly Click here
Wed, 30 Jun 2021
Closure of Trading Window
Intimation of Closure of Trading Window

Technical Scans View Details

Mon, 26 Jul 2021
Stock Underperforming Benchmark Index in both 1 Week and 3 Month Stock Underperforming Benchmark Index in both 1 Week and 3 Month
Stock Underperforming Sectoral Index in both 1 Week and 3 Month Stock Underperforming Sectoral Index in both 1 Week and 3 Month
Strongly Underperforming Benchmark index Strongly Underperforming Benchmark index
Strongly Underperforming Sectoral index Strongly Underperforming Sectoral index
Close Within 2 Year Low Zone Close Within 2 Year Low Zone

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. 154,391.34 1,403.90 +0.2%
Adani Transmission Ltd. 102,832.24 935.00 -2.7%
Sundram Fasteners Ltd. 15,507.47 738.00 -3.2%
Redington (India) Ltd. 12,533.66 320.90 -0.5%
MMTC Ltd. 7,140.00 47.60 -2.3%
Novartis India Ltd. 2,432.04 985.00 +0.5%
MSTC Ltd. 2,076.10 294.90 -1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 167.34 1,403.90 +0.2%
Adani Transmission Ltd. Consolidated 2021-03 84.01 935.00 -2.7%
Sundram Fasteners Ltd. Consolidated 2021-03 43.17 738.00 -3.2%
Redington (India) Ltd. Consolidated 2021-03 16.57 320.90 -0.5%
MMTC Ltd. Standalone 2020-12 0.00 47.60 -2.3%
Novartis India Ltd. Standalone 2021-03 116.37 985.00 +0.5%
MSTC Ltd. Consolidated 2021-03 18.38 294.90 -1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 9.00 1,403.90 +0.2%
Adani Transmission Ltd. Consolidated 2021-03 16.89 935.00 -2.7%
Sundram Fasteners Ltd. Consolidated 2021-03 6.61 738.00 -3.2%
Redington (India) Ltd. Consolidated 2021-03 2.54 320.90 -0.5%
MMTC Ltd. Standalone 2020-12 7.07 47.60 -2.3%
Novartis India Ltd. Standalone 2021-03 3.42 985.00 +0.5%
MSTC Ltd. Consolidated 2021-03 3.72 294.90 -1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 0.93 1,403.90 +0.2%
Adani Transmission Ltd. Consolidated 2021-03 4.89 935.00 -2.7%
Sundram Fasteners Ltd. Consolidated 2021-03 0.29 738.00 -3.2%
Redington (India) Ltd. Consolidated 2021-03 0.09 320.90 -0.5%
MMTC Ltd. Standalone 2020-03 4.23 47.60 -2.3%
Novartis India Ltd. Standalone 2020-03 0.00 985.00 +0.5%
MSTC Ltd. Consolidated 2020-03 0.55 294.90 -1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 4.38 1,403.90 +0.2%
Adani Transmission Ltd. Consolidated 2021-03 22.81 935.00 -2.7%
Sundram Fasteners Ltd. Consolidated 2021-03 16.70 738.00 -3.2%
Redington (India) Ltd. Consolidated 2021-03 17.02 320.90 -0.5%
MMTC Ltd. Standalone 2020-03 -20.23 47.60 -2.3%
Novartis India Ltd. Standalone 2020-03 1.36 985.00 +0.5%
MSTC Ltd. Consolidated 2020-03 23.14 294.90 -1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 7.88 1,403.90 +0.2%
Adani Transmission Ltd. Consolidated 2021-03 10.89 935.00 -2.7%
Sundram Fasteners Ltd. Consolidated 2021-03 17.31 738.00 -3.2%
Redington (India) Ltd. Consolidated 2021-03 21.81 320.90 -0.5%
MMTC Ltd. Standalone 2020-03 -2.16 47.60 -2.3%
Novartis India Ltd. Standalone 2020-03 4.73 985.00 +0.5%
MSTC Ltd. Consolidated 2020-03 22.93 294.90 -1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 39,537.13 1,403.90 +0.2%
Adani Transmission Ltd. Consolidated 2021-03 9,926.33 935.00 -2.7%
Sundram Fasteners Ltd. Consolidated 2021-03 3,644.29 738.00 -3.2%
Redington (India) Ltd. Consolidated 2021-03 56,945.86 320.90 -0.5%
MMTC Ltd. Standalone 2020-03 26,304.71 47.60 -2.3%
Novartis India Ltd. Standalone 2020-03 438.25 985.00 +0.5%
MSTC Ltd. Consolidated 2020-03 1,231.40 294.90 -1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Adani Enterprises Ltd. Consolidated 2021-03 746.32 1,403.90 +0.2%
Adani Transmission Ltd. Consolidated 2021-03 1,289.57 935.00 -2.7%
Sundram Fasteners Ltd. Consolidated 2021-03 362.71 738.00 -3.2%
Redington (India) Ltd. Consolidated 2021-03 786.61 320.90 -0.5%
MMTC Ltd. Standalone 2020-03 -220.48 47.60 -2.3%
Novartis India Ltd. Standalone 2020-03 10.08 985.00 +0.5%
MSTC Ltd. Consolidated 2020-03 99.71 294.90 -1.8%